Your shopping cart is currently empty

BAY-1128688 is a potent, orally bioavailable selective AKR1C3 inhibitor with an IC50 of less than 2 nM. It shows high selectivity for related AKR1C enzymes (1C1, 1C2, 1C4) and AKR1D1, with no significant activity on major nuclear hormone receptors. BAY-1128688 reduces endometriotic lesions in a marmoset model of endometriosis and is useful for research in endometriosis.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | BAY-1128688 is a potent, orally bioavailable selective AKR1C3 inhibitor with an IC50 of less than 2 nM. It shows high selectivity for related AKR1C enzymes (1C1, 1C2, 1C4) and AKR1D1, with no significant activity on major nuclear hormone receptors. BAY-1128688 reduces endometriotic lesions in a marmoset model of endometriosis and is useful for research in endometriosis. |
| Targets&IC50 | AKR1C3:<2 nM |
| Molecular Weight | 462.57 |
| Formula | C28H31FN2O3 |
| Cas No. | 1428988-21-9 |
| Smiles | C[C@@]12[C@]([C@]3([C@@](C=4C(CC3)=CC(C(N(CCC(O)=O)C)=O)=CC4)(CC1)[H])[H])(CC=C2C=5C=C(F)C=NC5)[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.